ScreenPoint Medical was founded in 2014 by Professor Nico Karssemeijer and Professor Sir Michael Brady, world leading experts in quantitative breast image analysis and computer aided detection. Both men have careers spanning decades at the forefront of innovation and both have been prolific entrepreneurs and contributors within their fields.
Earlier this month, Professor Brady, emeritus professor of the Department of Oncology at The University of Oxford, was elected to the National Academy of Engineering (NAE) as part of its Class of 2026, making him part of an elite group of only 356 international members.
Election to the US National Academy of Engineering is among the highest professional distinctions accorded to an engineer. Academy membership honors individuals who have made outstanding contributions to engineering research, practice, or education: in the case of Professor Brady, for his contributions to vision-based robotics as well as image-based medical diagnosis and treatment.
(shown left to right: Nico Karssemeijer, ScreenPoint CEO Pieter Kroese, and Mike Brady)
Separately in December, the noted physician and professor Dr. Mike Linver presented Professor Karssemeijer with the Honorary Beaver Lifetime Achievement Award, which celebrates his contributions to the field of mammographic imaging and to the countless lives he has impacted through the earlier detection of breast cancer in healthcare settings across the globe.
Professor Karssemeijer current serves as ScreenPoint Medical's Chief Scientific Officer and is a professor of Computer-Aided Diagnosis at Radboud University in The Netherlands.
The ScreenPoint Medical team could not be more proud to help further both founders' mission and cement their legacy. Together, their contributions are reshaping not only the standard of care and health outcomes within breast imaging, but helping to transform the future of health.